Beyond Anti-VEGF: Toward Integrated Precision Care in Diabetic Retinal Disease.

Gonzalez-Cortes JH, Gonzalez-Cantu JE, Bilgic A, March de Ribot F, Sudhalkar A, Kodjikian L, Pelayes D, Mathis T, Mohamed-Hamsho J

Open source

DOI
10.3390/pharmaceutics18091178
Published
2026 Sep 17
Container
Pharmaceutics
Publisher
Not recorded
Open access
unknown

Credibility signals

limited evidence Score 43/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.3390/pharmaceutics18091178,
  title = {Beyond Anti-VEGF: Toward Integrated Precision Care in Diabetic Retinal Disease.},
  author = {Gonzalez-Cortes JH and Gonzalez-Cantu JE and Bilgic A and March de Ribot F and Sudhalkar A and Kodjikian L and Pelayes D and Mathis T and Mohamed-Hamsho J},
  year = {2026},
  journal = {Pharmaceutics},
  doi = {10.3390/pharmaceutics18091178},
  url = {https://doi.org/10.3390/pharmaceutics18091178}
}

RIS

TY  - JOUR
TI  - Beyond Anti-VEGF: Toward Integrated Precision Care in Diabetic Retinal Disease.
AU  - Gonzalez-Cortes JH
AU  - Gonzalez-Cantu JE
AU  - Bilgic A
AU  - March de Ribot F
AU  - Sudhalkar A
AU  - Kodjikian L
AU  - Pelayes D
AU  - Mathis T
AU  - Mohamed-Hamsho J
PY  - 2026
JO  - Pharmaceutics
DO  - 10.3390/pharmaceutics18091178
UR  - https://doi.org/10.3390/pharmaceutics18091178
ER  - 

APA

JH, G., JE, G., A, B., F, M. D. R., A, S., L, K., D, P., T, M., & J, M. (2026). Beyond Anti-VEGF: Toward Integrated Precision Care in Diabetic Retinal Disease.. Pharmaceutics. https://doi.org/10.3390/pharmaceutics18091178

Source records